After reviewing Health Insurance Innovations' cash flow during the first half of 2019, Cantor Fitzgerald analyst Steven Halper is not that concerned about the company's use of cash. Excluding different items, the company generated free cash flow over the trailing 12 months, which makes the reported negative cash flow not a major concern, Halper tells investors in a research note. Looking ahead, it is entirely possible that Health Insurance will continue to use cash as it begins to build up its Medicare business, adds the analyst. However, he remains optimistic about its Medicare initiative, which he believes should enhance its valuation over time. Halper reiterates an Overweight rating on Health Insurance Innovations with an $80 price target.